WIERENGA WENDELL bought CYTK
January 15, 2026 · Form 4 insider transaction
WIERENGA WENDELL bought 98 shares of Cytokinetics, Incorporated at $63.44 per share, a transaction worth $6.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
98
Price
$63.44
Total value
$6.2K
InsiderWIERENGA WENDELL
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 15, 2026
Filing dateJanuary 16, 2026
Shares owned after32,542
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Fully vested shares of common stock received in lieu of cash retainer pursuant to Equity in Lieu of Cash Retainer Option available to members of our Board of Directors.